First-dose mRNA vaccination is sufficient to reactivate immunological memory to SARS-CoV-2 in subjects who have recovered from COVID-19.

MLA

Mazzoni, Alessio, et al. “First-Dose MRNA Vaccination Is Sufficient to Reactivate Immunological Memory to SARS-CoV-2 in Subjects Who Have Recovered from COVID-19.” Journal of Clinical Investigation, vol. 131, no. 12, June 2021, pp. 1–7. EBSCOhost, https://doi.org/10.1172/JCI149150.

APA

Mazzoni, A., Di Lauria, N., Maggi, L., Salvati, L., Vanni, A., Capone, M., Lamacchia, G., Mantengoli, E., Spinicci, M., Zammarchi, L., Kiros, S. T., Rocca, A., Lagi, F., Colao, M. G., Parronchi, P., Scaletti, C., Turco, L., Liotta, F., Rossolini, G. M., & Cosmi, L. (2021). First-dose mRNA vaccination is sufficient to reactivate immunological memory to SARS-CoV-2 in subjects who have recovered from COVID-19. Journal of Clinical Investigation, 131(12), 1–7. https://doi.org/10.1172/JCI149150

Chicago

Mazzoni, Alessio, Nicoletta Di Lauria, Laura Maggi, Lorenzo Salvati, Anna Vanni, Manuela Capone, Giulia Lamacchia, et al. 2021. “First-Dose MRNA Vaccination Is Sufficient to Reactivate Immunological Memory to SARS-CoV-2 in Subjects Who Have Recovered from COVID-19.” Journal of Clinical Investigation 131 (12): 1–7. doi:10.1172/JCI149150.